Feedback / Questions
Engensis (donaperminogene seltoplasmid) - Beijing Northland, Reyon Pharma, Helixmith
https://www.prnewswire.com/news-releases/paper-reporting-results-from-helixmiths-phase-3-gene-therapy-trial-for-painful-diabetic-neuropathy-was-one-of-the-top-10-most-downloaded-articles-in-clinical-and-translational-science-301501164.html
Mar 14, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next